Romiplostim - Latest Advances

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Journal: Cureus

Published: October 15, 2025

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

Journal: Expert review of hematology

Published: September 29, 2025

The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.

Journal: Gynecologic oncology

Published: September 18, 2025

Evaluation of the efficacy and safety of initial high-dose romiplostim for primary immune thrombocytopenia in the acute care setting.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: September 09, 2025

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 09, 2025

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Journal: Cureus

Published: August 25, 2025

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Journal: The Journal of the Association of Physicians of India

Published: August 21, 2025

Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation-Induced Premature Aging.

Journal: Pharmacology research & perspectives

Published: August 20, 2025

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Journal: Haematologica

Published: August 13, 2025

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Journal: BMJ open

Published: August 10, 2025

A new era in the treatment of aplastic anemia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2025

Longitudinal plasma proteomics in romiplostim-treated patients with immune thrombocytopenia.

Journal: British journal of haematology

Published: July 30, 2025

Filters

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis.

The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.

The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.

Evaluation of the efficacy and safety of initial high-dose romiplostim for primary immune thrombocytopenia in the acute care setting.

Evaluation of the efficacy and safety of initial high-dose romiplostim for primary immune thrombocytopenia in the acute care setting.

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Transplantation-mediated alloimmune thrombocytopenia following liver transplantation from a donor with ITP: a case report and review of the literature.

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Atypical Presentation in X-linked Immunodeficiency With Magnesium Defect, Epstein-Barr Virus (EBV) Infection, and Neoplasia (XMEN) Disease: A Case Report and Review of Emerging Therapies.

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Beyond Lungs: Hematuria as the Primary Presentation of Immune Thrombocytopenic Purpura in Case of Extrapulmonary Tuberculosis Complicated with Rifampicin-induced Thrombocytopenia Posing Diagnostic and Therapeutic Challenge.

Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation-Induced Premature Aging.

Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation-Induced Premature Aging.

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Romiplostim for aplastic anemia: beyond an eltrombopag alternative.

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

A new era in the treatment of aplastic anemia

A new era in the treatment of aplastic anemia

Longitudinal plasma proteomics in romiplostim-treated patients with immune thrombocytopenia.

Longitudinal plasma proteomics in romiplostim-treated patients with immune thrombocytopenia.